Duloxetine: the pharmacological and clinical profile of a drug from the group of serotonin and noradrenaline reuptake inhibitors | Zendy

Marcin Wojtera | Zendy; Tomasz Sobów | Zendy

Open Access

Duloxetine: the pharmacological and clinical profile of a drug from the group of serotonin and noradrenaline reuptake inhibitors

Author(s) -

Marcin Wojtera,

Tomasz Sobów

Publication year - 2018

Publication title -

psychiatria i psychologia kliniczna

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.14

H-Index - 7

eISSN - 2451-0645

pISSN - 1644-6313

DOI - 10.15557/pipk.2018.0010

Subject(s) - duloxetine , serotonin , reuptake inhibitor , pharmacology , drug , medicine , psychology , receptor , alternative medicine , pathology

Marcin Wojtera1, Tomasz Sobów2 © Medical Communications Sp. z o.o. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (CC BY-NC-ND). Reproduction is permitted for personal, educational, non-commercial use, provided that the original article is in whole, unmodified, and properly cited. Received: 16.02.2018 Accepted: 18.02.2018 Published: 29.03.2018 © Psychiatr Psychol Klin 2018, 18 (1), p. 74–80 DOI: 10.15557/PiPK.2018.0010 Duloksetyna – profil farmakologiczny i kliniczny leku z grupy inhibitorów zwrotnego wychwytu serotoniny i noradrenaliny Duloxetine: the pharmacological and clinical profile of a drug from the group of serotonin and noradrenaline reuptake inhibitors

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research